Recent work reveals the need to re-examine the current paradigms for managing the potential identifiability of genomic and other "omic"-type data. [Also see News story and Report by Gymrek et al. ]
No takes yet. Share an insight, caveat, or question.
Rodriguez et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: